Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. Medical device firms eye sustainability amidst regulatory changes 2. Singapore launches online tool for health insurance planning 3. Japan’s medical device market to be valued at $42.9b by 2029 4. NUH, Jaga-Me ink MoU for supportive and palliative care 5. Saudi Arabia’s pharmaceutical market to hit $16.7b by 2029Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
PicoSure® Pro takes picosecond laser technology to unprecedented levels of performance.
Commentary
Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy